|
KMID : 1214920130190020153
|
|
Soonchunhyang Medical Science
2013 Volume.19 No. 2 p.153 ~ p.157
|
|
|
Reactivation of Hepatitis B Virus Following Anti-Tumor Necrosis Factor-α Therapy
|
|
Jang Seung-Jun
Jung Young-Kul
Kim Si-Hun
Kim Su-Ji
Kwon Oh-Sang
Kim Yun-Soo
Choi Duck-Joo
Kim Ju-Hyeon
|
|
|
Abstract
|
|
|
|
Anti-tumor necrosis factor (TNF)-α therapy is being increasingly used to treat several rheumatic diseases and inflammatory bowel diseases. However, treatment with anti-TNF-α therapy of patients with a concurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection can promote viral reactivation and potentially fatal liver failure. The medical records of 176 patients who had been treated with an anti-TNF-α therapy at single center from January 2010 to December 2012 were retrospectively analyzed. Of the 176 patients, the hepatitis B surface antigen (HBsAg) status of 114 (64.8%) were tested at the baseline. Five (4.4%) of them were HBsAgpositive, and 109 (95.6%) were negative. Only 10 of the HBsAg-negative patients (9.2%) were checked for hepatitis B core antigen. Ninety-one patients were checked for anti-HCV, and two (2.2%) were positive. After their anti-TNF-α therapy, HBV reactivation was confirmed in two patients. The reactivation of HBV after the anti-TNF-α therapy was observed in the HBsAg-positive patients.
|
|
|
KEYWORD
|
|
|
Hepatitis B, Hepatitis B surface antigens, Tumor necrosis factor-alpha, Rheumatic diseases, Inflammatory bowel diseases
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|